Calamos Advisors
QGENF

Calamos Advisors’s QIAGEN NV QGENF Stock Holding History

Calamos Advisors’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-844,000
Closed -$20.1M – 700
2013
Q4 		$20.1M Sell
844,000
-197,800
-19% -$4.71M 0.13% 182
2013
Q3 		$22.3M Sell
1,041,800
-17,000
-2% -$364K 0.14% 164
2013
Q2 		$21.1M Buy
+1,058,800
New +$21.1M 0.14% 165

Other funds holding QGENF

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Calamos Advisors's QGENF Position: Q1 2014 in Review

Calamos Advisors sold out of QIAGEN NV (QGENF) in Q1 2014, closing a stake of 844,000 shares — an estimated $20.1M sold.

Calamos Advisors first reported a position in QGENF in Q2 2013 and held it in 3 quarters. The position peaked at $22.3M in Q3 2013. 166 funds tracked by Wall St. Rank hold QGENF as of Q1 2014.

  • Calamos Advisors reported no remaining QIAGEN NV position as of Q1 2014 after selling out during the quarter.
  • Calamos Advisors sold 844,000 QIAGEN NV shares in Q1 2014, an estimated $20.1M.
  • Calamos Advisors first reported a position in QIAGEN NV in Q2 2013 and held it in 3 quarters.
  • Calamos Advisors's QIAGEN NV position peaked at $22.3M in Q3 2013.
  • 166 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2014.

Based on Calamos Advisors's 13F filing for Q1 2014, filed 16 May 2014.